Craig Stuart Millian's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 934,645 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Hol... | Craig Stuart Millian | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 934,645 | 934,645 | - | - | Stock Option (right to buy) | |
Corbus Pharmaceuticals Hol... | Craig Stuart Millian | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 10 Aug 2022 | 5,000 | 27,000 (0%) | 0% | 0.3 | 1,273 | Common Stock |
Corbus Pharmaceuticals Hol... | Craig Stuart Millian | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 10 Mar 2022 | 10,000 | 22,000 (0%) | 0% | 0.4 | 3,700 | Common Stock |
Corbus Pharmaceuticals Hol... | Craig Stuart Millian | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 402,900 | 402,900 | - | - | Stock Option (right to buy) | |
Corbus Pharmaceuticals Hol... | Craig Stuart Millian | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 307,300 | 307,300 | - | - | Stock Option (right to buy) | |
Corbus Pharmaceuticals Hol... | Craig Stuart Millian | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 307,300 | 307,300 | - | - | Stock Option (right to buy) |